Clinical aspects of the treatment of obesity by drugs: a review.
The safety, short-term and long-term efficacy of appetite-suppressant drugs are reviewed. Seven drugs widely available on prescription under the UK national health service are discussed.
D000662:Amphetamines / Q000009:adverse effects; D001067:Appetite Depressants / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004053:Diethylpropion / Q000009:adverse effects; D004361:Drug Tolerance; D005260:Female; D005277:Fenfluramine / Q000009:adverse effects; D006801:Humans; D008454:Mazindol / Q000009:adverse effects; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010633:Phenmetrazine / Q000009:adverse effects; D010645:Phentermine / Q000009:adverse effects
D000662:Amphetamines; D001067:Appetite Depressants; D005277:Fenfluramine; D010645:Phentermine; D008454:Mazindol; D004053:Diethylpropion; D010633:Phenmetrazine